News Express: UM hosts international symposium on natural products and immunity
新聞快訊：澳大辦首屆天然產物與免疫國際研討會
徐建
Xu Jian
澳大辦首屆天然產物與免疫國際研討會
澳門大學中華醫藥研究院、中藥機制與質量全國重點實驗室、免疫調節研究中心舉辦首屆“天然產物與免疫國際研討會”，吸引逾百名來自中國內地、港澳地區以及美國、愛爾蘭、墨西哥的專家學者、科研人員及學生參與，共同探討天然產物在調節免疫、炎症反應研究的最新進展。
澳大副校長徐建表示，今年適逢澳門大學建校45周年，是次研討會不僅彰顯了大學對卓越研究的持久追求，更體現了其在生命科學、轉化醫學及中醫藥現代化領域的高質量佈局。她強調，中醫藥與健康科學已成為澳門創新驅動發展的重要引擎，期望透過是次國際研討會，進一步推動研究成果轉化，為產業發展與社會福祉貢獻力量。
澳大中華醫藥研究院院長兼中藥機制與質量全國重點實驗室主任陳新指出，研討會旨在探索天然產物，特別是傳統醫學中使用的天然產物，在免疫調節中的治療潛力與作用機制；並通過邀請多位國際頂尖學者就中藥機制、免疫治療靶標、系統醫學等前沿領域發表專題演講，為學術交流及產業轉化搭建高規格平台，促進“基礎研究—臨床應用—轉化開發”的深度協同。
香港大學生物醫學學院教授金冬雁、美國愛荷華大學榮休教授William M. Nauseef、墨西哥國立理工學院教授Michael Schnoor、美國威斯塔研究所助理教授Ian Tietjen、愛爾蘭戈爾韋大學教授Abhay Pandit、澳門科技大學副校長姜志宏、香港中文大學教授林志秀、暨南大學教授陳國兵、中國醫學科學院蘇州系統醫學研究所研究員馬瑜婷、 澳門大學教授梁麗嫻和副教授何歡歡出席研討會。
研討會期間還舉行了澳門重點研發（國家需要）項目中藥免疫調節機制及轉化研究項目啟動會。項目主持人陳新詳細介紹了中藥機制與質量全國重點實驗室及項目的戰略規劃；馬瑜婷、廣州白雲山陳李濟藥廠有限公司董事長劉國偉作為合作方代表亦分別介紹了各自單位的研究佈局。
澳大中華醫藥研究院將打造“天然產物與免疫國際研討會”為年度學術活動，將其構建成該領域具國際影響力的學術高地，進一步提升澳大在中藥免疫調節研究領域的學術優勢。
欲瀏覽官網版可登入以下連結:
https://www.um.edu.mo/zh-hant/news-and-press-releases/press-release/detail/63719/
UM hosts international symposium on natural products and immunity
The Institute of Chinese Medical Sciences (ICMS), the State Key Laboratory of Mechanism and Quality of Chinese Medicine (SKL-MQCM), and the Centre for Immune Regulation at the University of Macau (UM) jointly organised an international symposium titled ‘Natural Products and Immunity’. Over 100 experts, scholars, researchers, and students from Macao, Hong Kong, and the Chinese mainland, as well as the US, Ireland, and Mexico, attended the event to explore the latest advances in the research on the role of natural products in modulating immune responses and inflammation.
Xu Jian, vice rector of UM, said in her speech that the symposium reflected UM’s commitment to excellence in research and highlighted the university’s strategic focus on life sciences, translational medicine, and the modernisation of Chinese medicine. She added that Chinese medicine and health sciences have become key drivers of innovation-led development in Macao, and expressed hope that the symposium would accelerate the translation of research outcomes into tangible benefits for industry and public wellbeing.
Chen Xin, director of ICMS and director of SKL-MQCM, said in his speech that the aim of the symposium was to explore the therapeutic potential and mechanism of natural products, especially those used in traditional medicine, in immune modulation. By having leading international scholars deliver keynote presentations on cutting-edge topics, the event would provide a platform for academic exchange and industrialisation, fostering synergy between basic research, clinical application, and translational development.
The symposium also featured the launch ceremony of Macao’s key R&D projects on the mechanisms and translational research of immune modulation by Chinese medicine.
To read the news on UM’s official website, please visit the following link:
https://www.um.edu.mo/news-and-press-releases/press-release/detail/63719/